Related Experiment Video
Updated: Aug 9, 2026

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
Published on: February 9, 2014
BACTERIOPHAGE M13 MODULATES THE SEPSIS-RELATED INFLAMMATORY RESPONSES AND ORGAN DAMAGE IN A CLP MODEL
Arezou Rahimi1, Sara Soudi1, Saeid Vakilian2
1Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Abstract:
Background: Sepsis is a life-threatening disorder that leads to the induction of inflammatory responses and organ failure. Phage therapy is a new approach to controlling infections resistant to common treatments, including sepsis. Several studies have shown the effect of lytic bacteriophages on infection control by reducing the bacterial load. The present study deals with lysogenic bacteriophage M13 on the inflammatory responses caused by cecal ligation and puncture (CLP)-induced sepsis in a mouse model. Methods Bacteriophage M13 harvested from ER2738, titrated, and confirmed by transmission electron microscopy analysis. In vitro toxicity and immunomodulatory effect of bacteriophage M13 were assessed on splenocytes by measurement of cell viability and the production level of cytokines, nitric oxide, and reactive oxygen species. For in vivo experiments, 8-weeks-old male C57BL/6 mice were randomly divided into the following three groups: CLP + NS (treated with normal saline), CLP + M13 (treated with an intraperitoneal injection of 10 9 PFU/mL of bacteriophage M13), and sham + NS (induced surgery but without ligation and puncture, treated with NS). The mice were killed at different time points after surgery (6, 24, 48, and 72, n = 10 for each time point of each group). The kidney, liver, and lungs were harvested for histopathological analysis, and blood was obtained for cytokine and liver enzyme assay. The spleen was used to assess the bacterial load using colony-forming unit assay. The rectal temperature and survival were evaluated during the study. Results According to the in vitro results, 10 9 PFU/mL of bacteriophage M13 was not toxic and did not affect the level of cytokine, nitric oxide, and reactive oxygen species production by splenocytes, but it reduced the inflammatory response of splenocytes in responses to LPS. In vivo studies indicated that the amount of proinflammatory cytokines, liver enzymes, bacterial load, and organ failure were decreased in the CLP + M13 group compared with CLP + NS, whereas the survival rate was increased. Conclusions These experiments demonstrated that bacteriophage M13 could lessen the consequences related to sepsis in CLP mice and can be considered a therapeutic approach in sepsis.
Insights
Lysogenic bacteriophage M13 therapy reduced inflammatory responses and organ failure in a mouse model of sepsis. This phage therapy approach shows promise for treating sepsis by decreasing bacterial load and improving survival rates.
Area of Science:
- Microbiology
- Immunology
- Medical Science
Background:
- Sepsis is a life-threatening condition characterized by inflammation and organ failure.
- Bacteriophage therapy offers a novel strategy for combating antibiotic-resistant infections like sepsis.
- Lysogenic bacteriophages, specifically M13, are explored for their immunomodulatory effects in sepsis.
Purpose of the Study:
- To evaluate the efficacy of lysogenic bacteriophage M13 in mitigating inflammatory responses and organ damage in a mouse model of sepsis.
- To assess the in vitro toxicity and immunomodulatory effects of bacteriophage M13 on splenocytes.
- To determine the in vivo impact of bacteriophage M13 on bacterial load, cytokine levels, organ function, and survival in sepsis.
Main Methods:
- Bacteriophage M13 was characterized and its in vitro toxicity and immunomodulatory effects on splenocytes were assessed.
- Cecal ligation and puncture (CLP) induced sepsis in C57BL/6 mice, divided into groups receiving normal saline or bacteriophage M13.
- Mice were monitored for histopathology, cytokine levels, liver enzymes, bacterial load, rectal temperature, and survival at various time points.
Main Results:
- In vitro, bacteriophage M13 (10^9 PFU/mL) showed no toxicity to splenocytes and reduced LPS-induced inflammatory responses.
- In vivo, bacteriophage M13 treatment significantly decreased proinflammatory cytokines, liver enzymes, bacterial load, and organ failure in CLP mice.
- Rectal temperature was normalized, and survival rates were significantly increased in the bacteriophage M13-treated group compared to controls.
Conclusions:
- Lysogenic bacteriophage M13 demonstrates significant therapeutic potential in reducing sepsis-induced inflammation and organ damage.
- Bacteriophage M13 can effectively lower bacterial load and mitigate systemic inflammatory responses in a sepsis model.
- Phage therapy using bacteriophage M13 presents a promising alternative treatment strategy for sepsis management.
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Regulation of Bacterial Virulence
Acute Inflammation III: Local and Systemic Effects

